X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4912) 4912
Book Review (557) 557
Publication (183) 183
Newsletter (17) 17
Book Chapter (12) 12
Conference Proceeding (5) 5
Book / eBook (3) 3
Dissertation (3) 3
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (4414) 4414
humans (4030) 4030
male (2910) 2910
bleomycin - adverse effects (2426) 2426
female (2254) 2254
adult (2182) 2182
middle aged (1970) 1970
bleomycin - administration & dosage (1956) 1956
bleomycin (1614) 1614
antineoplastic combined chemotherapy protocols - therapeutic use (1548) 1548
antineoplastic combined chemotherapy protocols - adverse effects (1441) 1441
aged (1292) 1292
oncology (1240) 1240
chemotherapy (912) 912
animals (904) 904
bleomycin - therapeutic use (893) 893
adolescent (886) 886
cisplatin - administration & dosage (837) 837
doxorubicin - administration & dosage (776) 776
vincristine - administration & dosage (693) 693
treatment outcome (652) 652
abridged index medicus (606) 606
cancer (603) 603
cisplatin - adverse effects (595) 595
hodgkin disease - drug therapy (585) 585
etoposide - administration & dosage (561) 561
doxorubicin - adverse effects (552) 552
vinblastine - administration & dosage (537) 537
testicular neoplasms - drug therapy (531) 531
mice (522) 522
combined modality therapy (520) 520
cyclophosphamide - administration & dosage (519) 519
pulmonary fibrosis - chemically induced (518) 518
vincristine - adverse effects (467) 467
prednisone - administration & dosage (453) 453
carcinoma, squamous cell - drug therapy (435) 435
antineoplastic combined chemotherapy protocols - administration & dosage (433) 433
neoplasm staging (421) 421
vinblastine - adverse effects (415) 415
prognosis (409) 409
follow-up studies (406) 406
cisplatin (400) 400
etoposide - adverse effects (386) 386
cyclophosphamide - adverse effects (351) 351
drug therapy, combination (346) 346
antibiotics, antineoplastic - adverse effects (340) 340
respiratory system (340) 340
therapy (338) 338
antineoplastic agents - adverse effects (332) 332
methotrexate - administration & dosage (329) 329
time factors (325) 325
hematology (322) 322
retrospective studies (316) 316
disease (314) 314
vinblastine (313) 313
child (305) 305
prednisone - adverse effects (305) 305
dacarbazine - administration & dosage (304) 304
lung - drug effects (303) 303
drug administration schedule (301) 301
survival rate (299) 299
lung - pathology (289) 289
pulmonary fibrosis (286) 286
care and treatment (283) 283
prospective studies (281) 281
remission induction (276) 276
radiotherapy (272) 272
procarbazine - administration & dosage (271) 271
combination chemotherapy (264) 264
fibrosis (263) 263
rats (261) 261
risk factors (259) 259
pulmonary fibrosis - pathology (258) 258
disease-free survival (253) 253
disease models, animal (248) 248
methotrexate - adverse effects (245) 245
neoplasms, germ cell and embryonal - drug therapy (244) 244
dose-response relationship, drug (243) 243
etoposide (242) 242
toxicity (240) 240
young adult (238) 238
survival analysis (237) 237
lymphoma, non-hodgkin - drug therapy (235) 235
dacarbazine - adverse effects (233) 233
doxorubicin - therapeutic use (230) 230
pharmacology & pharmacy (228) 228
aged, 80 and over (219) 219
tumors (215) 215
surgery (214) 214
hodgkin disease - radiotherapy (212) 212
antineoplastic agents - therapeutic use (203) 203
hodgkin disease - pathology (203) 203
head and neck neoplasms - drug therapy (198) 198
bleomycin - pharmacology (197) 197
clinical trials as topic (197) 197
vincristine - therapeutic use (197) 197
inflammation (195) 195
antineoplastic agents - administration & dosage (189) 189
lung diseases - chemically induced (189) 189
testicular cancer (188) 188
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4288) 4288
Japanese (166) 166
German (127) 127
French (122) 122
Chinese (60) 60
Spanish (45) 45
Russian (35) 35
Italian (25) 25
Polish (22) 22
Dutch (11) 11
Hungarian (9) 9
Czech (7) 7
Portuguese (6) 6
Danish (3) 3
Hebrew (3) 3
Korean (3) 3
Norwegian (3) 3
Romanian (2) 2
Turkish (2) 2
Croatian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 07/2011, Volume 365, Issue 3, pp. 203 - 212
BEACOPP combination chemotherapy was compared with ABVD chemotherapy in advanced Hodgkin's disease. BEACOPP therapy was associated with higher initial rates of... 
CELL TRANSPLANT | MEDICINE, GENERAL & INTERNAL | VINORELBINE | MOPP | DISEASE | REGIMEN | IFOSFAMIDE | CHEMOTHERAPY | STANDARD | HYBRID | FERTILITY | Doxorubicin - therapeutic use | Dacarbazine - adverse effects | Dacarbazine - therapeutic use | Humans | Middle Aged | Salvage Therapy | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Vinblastine - therapeutic use | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Young Adult | Hodgkin Disease - radiotherapy | Bleomycin - therapeutic use | Vinblastine - adverse effects | Hodgkin Disease - drug therapy | Hodgkin Disease - mortality | Adult | Female | Etoposide - adverse effects | Prednisone - adverse effects | Kaplan-Meier Estimate | Proportional Hazards Models | Hematopoietic Stem Cell Transplantation | Etoposide - therapeutic use | Combined Modality Therapy | Bleomycin - adverse effects | Remission Induction | Disease-Free Survival | Procarbazine - adverse effects | Procarbazine - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Hodgkin Disease - therapy | Adolescent | Vincristine - therapeutic use | Vincristine - adverse effects | Neoplasm Staging | Doxorubicin - adverse effects | Prednisone - therapeutic use | Procarbazine | Vinblastine | Disease | Etoposide | Prednisone | Family medical history | Radiation therapy | Patients | Lymphoma | Doxorubicin | Survival | Vincristine | Studies | Hepatitis | Dacarbazine | Cyclophosphamide | Chemotherapy | Bleomycin | Tomography | Lymphomas | Hodgkin's disease | Index Medicus | Abridged Index Medicus
Journal Article
Lancet, The, ISSN 0140-6736, 2012, Volume 379, Issue 9828, pp. 1791 - 1799
Summary Background The intensity of chemotherapy and need for additional radiotherapy in patients with advanced stage Hodgkin's lymphoma has been unclear. We... 
Internal Medicine | SURVIVAL | ABVD | MEDICINE, GENERAL & INTERNAL | COMBINATIONS | POSITRON-EMISSION-TOMOGRAPHY | DISEASE | PROGNOSTIC SCORE | RISK | STANFORD-V | PROGRESSION | MOPP/ABV HYBRID | Doxorubicin - therapeutic use | Prospective Studies | Hodgkin Disease - pathology | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Positron-Emission Tomography | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Hodgkin Disease - radiotherapy | Bleomycin - therapeutic use | Treatment Failure | Hodgkin Disease - drug therapy | Adult | Female | Radiotherapy Dosage | Etoposide - adverse effects | Prednisone - adverse effects | Proportional Hazards Models | Etoposide - therapeutic use | Treatment Outcome | Bleomycin - adverse effects | Procarbazine - adverse effects | Procarbazine - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Survival Analysis | Vincristine - therapeutic use | Vincristine - adverse effects | Neoplasm Staging | Doxorubicin - adverse effects | Prednisone - therapeutic use | Chemotherapy | Usage | Care and treatment | PET imaging | Diagnosis | Hodgkin's disease | Cancer | Medical imaging | Meetings | Patient safety | Oncology | Lymphomas | Histology | Radiation therapy | Ovarian cancer | Index Medicus | Abridged Index Medicus
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2013, Volume 31, Issue 5, pp. 592 - 598
Purpose To assess therapy-related acute myeloid leukemia/myelodysplastic syndrome (t-AML/MDS) risk in patients treated for Hodgkin lymphoma (HL) on successive... 
2ND CANCER-RISK | RANDOMIZED-TRIALS | ONCOLOGY | DNA TOPOISOMERASE-II | ALKYLATING-AGENTS | COMBINED-MODALITY TREATMENT | DISEASE | MYELOID-LEUKEMIA | MYELODYSPLASTIC SYNDROMES | CHEMOTHERAPY | ACUTE PROMYELOCYTIC LEUKEMIA | Dacarbazine - adverse effects | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Hodgkin Disease - pathology | Humans | Leukemia, Myeloid, Acute - epidemiology | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Mechlorethamine - adverse effects | Male | Risk | Leukemia, Myeloid, Acute - etiology | Incidence | Hodgkin Disease - radiotherapy | Melphalan - adverse effects | Chemotherapy, Adjuvant - adverse effects | Radiotherapy, Adjuvant - adverse effects | Vinblastine - adverse effects | Hodgkin Disease - drug therapy | Adult | Female | Retrospective Studies | Databases, Factual | Radiotherapy Dosage | Prednisone - adverse effects | Drug Administration Schedule | California - epidemiology | Clinical Trials as Topic | Bleomycin - adverse effects | Academic Medical Centers | Myelodysplastic Syndromes - epidemiology | Myelodysplastic Syndromes - etiology | Neoplasms, Second Primary - epidemiology | Neoplasms, Second Primary - etiology | Methotrexate - adverse effects | Procarbazine - adverse effects | Vincristine - adverse effects | Neoplasm Staging | Doxorubicin - adverse effects | Index Medicus | Hema14 | Hema13 | Hema12 | ORIGINAL REPORTS
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 11/2014, Volume 32, Issue 32, pp. 3651 - 3658
Purpose The Children's Oncology Group study AHOD0031, a randomized phase III study, was designed to evaluate the role of early chemotherapy response in... 
TRIAL | MORTALITY | ABVD | POSITRON-EMISSION-TOMOGRAPHY | ONCOLOGY | INVOLVED-FIELD RADIATION | PEDIATRIC-PATIENTS | DISEASE | FOLLOW-UP | CHILDHOOD-CANCER SURVIVOR | NO RADIOTHERAPY | Cyclophosphamide - administration & dosage | Hodgkin Disease - pathology | Humans | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Child, Preschool | Dexamethasone - adverse effects | Infant | Male | Cytarabine - adverse effects | Cyclophosphamide - adverse effects | Cisplatin - administration & dosage | Dose-Response Relationship, Drug | Young Adult | Hodgkin Disease - radiotherapy | Hodgkin Disease - drug therapy | Vincristine - administration & dosage | Female | Child | Infant, Newborn | Doxorubicin - administration & dosage | Prednisone - administration & dosage | Dexamethasone - administration & dosage | Etoposide - adverse effects | Prednisone - adverse effects | Risk Factors | Etoposide - administration & dosage | Treatment Outcome | Combined Modality Therapy | Bleomycin - administration & dosage | Bleomycin - adverse effects | Remission Induction | Cytarabine - administration & dosage | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Cisplatin - adverse effects | Vincristine - adverse effects | Doxorubicin - adverse effects | Index Medicus | Pedi9 | ORIGINAL REPORTS | Hema14
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2013, Volume 31, Issue 6, pp. 684 - 691
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 01/2013, Volume 31, Issue 2, pp. 231 - 239
Purpose To optimize fertility advice in patients with Hodgkin lymphoma (HL) before therapy and during survivorship, information on the impact of chemotherapy... 
INHIBIN-B | PRESERVATION | OUTCOME MEASURE | OVARIAN RESERVE | ONCOLOGY | TERM FOLLOW-UP | DISEASE | FEMALE CANCER SURVIVORS | ANTI-MULLERIAN HORMONE | CHEMOTHERAPY | SERUM MARKER | Procarbazine - administration & dosage | Cyclophosphamide - administration & dosage | Dacarbazine - adverse effects | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Vinblastine - administration & dosage | Cyclophosphamide - adverse effects | Gonadotropin-Releasing Hormone - analogs & derivatives | Fertility - physiology | Fertility Preservation | Young Adult | Vinblastine - adverse effects | Follicle Stimulating Hormone - blood | Hodgkin Disease - drug therapy | Oligospermia - epidemiology | Vincristine - administration & dosage | Adult | Female | Gonadotropin-Releasing Hormone - therapeutic use | Hodgkin Disease - physiopathology | Inhibins - blood | Menstrual Cycle - drug effects | Testosterone - blood | Menstrual Cycle - physiology | Doxorubicin - administration & dosage | Dacarbazine - administration & dosage | Prednisone - administration & dosage | Etoposide - adverse effects | Prednisone - adverse effects | Survivors | Etoposide - administration & dosage | Ovary - physiology | Hodgkin Disease - epidemiology | Bleomycin - administration & dosage | Bleomycin - adverse effects | Germany - epidemiology | Randomized Controlled Trials as Topic | Pregnancy | Testis - physiology | Hodgkin Disease - blood | Procarbazine - adverse effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Vincristine - adverse effects | Doxorubicin - adverse effects | Index Medicus
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 02/2012, Volume 366, Issue 5, pp. 399 - 408
In patients with limited-stage Hodgkin's disease, ABVD chemotherapy alone resulted in a higher rate of long-term (12-year) survival than either radiation... 
CLINICAL-PRACTICE GUIDELINES | MEDICINE, GENERAL & INTERNAL | INTERGROUP TRIAL | RANDOMIZED-TRIALS | DISEASE | DOXORUBICIN | VINBLASTINE | BLEOMYCIN | FIELD RADIOTHERAPY | CHEMOTHERAPY | COOPERATIVE-ONCOLOGY-GROUP | Doxorubicin - therapeutic use | Dacarbazine - adverse effects | Follow-Up Studies | Dacarbazine - therapeutic use | Humans | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Neoplasms, Second Primary - mortality | Radiotherapy - adverse effects | Vinblastine - therapeutic use | Cause of Death | Hodgkin Disease - radiotherapy | Bleomycin - therapeutic use | Vinblastine - adverse effects | Hodgkin Disease - drug therapy | Hodgkin Disease - mortality | Adult | Female | Treatment Outcome | Combined Modality Therapy | Bleomycin - adverse effects | Hodgkin Disease - complications | Heart Diseases - mortality | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Survival Analysis | Neoplasm Staging | Doxorubicin - adverse effects | Drugs | Usage | Care and treatment | Vinblastine | Patient outcomes | Product/Service Evaluations | Radiotherapy | Doxorubicin | Dacarbazine | Bleomycin | Dosage and administration | Drug therapy, Combination | Drug therapy | Hodgkin's disease | Medical research | Clinical trials | Radiation therapy | Lymphoma | Survival | Patients | Chemotherapy | Lymphomas | Index Medicus | Abridged Index Medicus
Journal Article
Blood, ISSN 0006-4971, 03/2014, Volume 123, Issue 11, pp. 1658 - 1664
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2013, Volume 14, Issue 13, pp. 1348 - 1356
Journal Article
Journal of clinical endocrinology and metabolism, ISSN 0021-972X, 2007, Volume 92, Issue 10, pp. 3869 - 3874
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 11/2012, Volume 30, Issue 33, pp. 4117 - 4123
Purpose Although the outcome of patients with HIV-related Hodgkin lymphoma (HIV-HL) has markedly improved since the introduction of combined antiretroviral... 
PROGNOSTIC-FACTORS | ONCOLOGY | INFECTION HD-HIV | ACTIVE ANTIRETROVIRAL THERAPY | DISEASE | RANDOMIZED-TRIAL | STANFORD-V | STEM-CELL TRANSPLANTATION | PATIENTS PTS | IMMUNODEFICIENCY | CHEMOTHERAPY | Procarbazine - administration & dosage | Cyclophosphamide - administration & dosage | Dacarbazine - adverse effects | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prognosis | Prospective Studies | Hodgkin Disease - pathology | Humans | Lymphoma, AIDS-Related - pathology | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Vinblastine - administration & dosage | Cyclophosphamide - adverse effects | Young Adult | Hodgkin Disease - radiotherapy | Vinblastine - adverse effects | Hodgkin Disease - drug therapy | Vincristine - administration & dosage | Adult | Female | Doxorubicin - administration & dosage | Lymphoma, AIDS-Related - drug therapy | Dacarbazine - administration & dosage | Prednisone - administration & dosage | Etoposide - adverse effects | Prednisone - adverse effects | Etoposide - administration & dosage | Treatment Outcome | Combined Modality Therapy | Bleomycin - administration & dosage | Bleomycin - adverse effects | Remission Induction | Disease-Free Survival | Procarbazine - adverse effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | HIV Infections - complications | Lymphoma, AIDS-Related - radiotherapy | Vincristine - adverse effects | Aged | Neoplasm Staging | Doxorubicin - adverse effects | Index Medicus
Journal Article